Co-Diagnostics, Inc. Forecast, price target & analysts
Co-Diagnostics, Inc. Target price 2026 - Analyst rating & recommendation
Co-Diagnostics, Inc. Classifications & Recommendation
Co-Diagnostics, Inc. Price Target
| Target Price | $4.08 |
| Price | $0.95 |
| Potential |
331.43%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Co-Diagnostics, Inc. 2027 .
The average Co-Diagnostics, Inc. target price is $4.08.
This is
331.43%
register free of charge
$4.20
344.12%
register free of charge
$4.04
327.20%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Co-Diagnostics, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Co-Diagnostics, Inc. stock has an average upside potential 2027 of
331.43%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.62 | 0.64 |
| 84.18% | 3.15% | |
| Net Margin | -7,564.52% | -9,456.46% |
| 687.80% | 25.01% |
4 Analysts have issued a sales forecast Co-Diagnostics, Inc. 2026 . The average Co-Diagnostics, Inc. sales estimate is
This results in the following potential growth metrics:
4 Co-Diagnostics, Inc. Analysts have issued a net profit forecast 2026. The average Co-Diagnostics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -35.25 | -12.39 |
| 5.32% | 64.85% | |
| P/E | negative | |
| EV/Sales | 4.85 |
4 Analysts have issued a Co-Diagnostics, Inc. forecast for earnings per share. The average Co-Diagnostics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Co-Diagnostics, Inc....
Current Co-Diagnostics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | Jan 23 2026 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Nov 26 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 16 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 19 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Sep 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
Jan 23 2026 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Nov 26 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 16 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 19 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Sep 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
